BridgeMD
New treatment option for Stroke
Official title Comparative Effects of Mirror Therapy and Cognitive Orientation to Daily Occupational Performance in Stroke: A Randomized Controlled Trial
ClinicalTrials.gov ID: NCT07546864
What this study is testing
- What it's testing
- This study aims to compare the effectiveness of three rehabilitation approaches in individuals with stroke: mirror therapy (MT), cognitive orientation to daily occupational performance (CO-OP), and conventional occupational therapy (COT), all combined with robotic balance training. A total of 45 individuals with subacute and chronic stroke will be randomly assigned to one of three groups.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- \- Individuals diagnosed with ischemic or hemorrhagic stroke
- Age 18 years and older
- Subacute (3-6 months post-stroke) or chronic stage (6-12 months post-stroke)
- Brunnstrom Motor Recovery Stage ≥3 for upper extremity, ≥4 for hand, and ≥4 for lower extremity
- Mini-Mental State Examination (MMSE) score ≥24
You likely can't join if
- \- Poor motor coordination or major medical problems that would prevent participation
- Presence of Wernicke's aphasia
- Botulinum toxin injection within the last 3 months
- Psychiatric conditions that may interfere with participation (e.g., depression, ongoing psychiatric treatment, low motivation)
See the full eligibility criteria
- \- Individuals diagnosed with ischemic or hemorrhagic stroke
- Age 18 years and older
- Subacute (3-6 months post-stroke) or chronic stage (6-12 months post-stroke)
- Brunnstrom Motor Recovery Stage ≥3 for upper extremity, ≥4 for hand, and ≥4 for lower extremity
- Mini-Mental State Examination (MMSE) score ≥24
- No severe visual, orthopedic, or additional neurological impairments
- Not participating in another study during the research period
- Voluntary consent to participate in the study
- \- Poor motor coordination or major medical problems that would prevent participation
- Presence of Wernicke's aphasia
- Botulinum toxin injection within the last 3 months
- Psychiatric conditions that may interfere with participation (e.g., depression, ongoing psychiatric treatment, low motivation)
The study team makes the final eligibility decision.
Where it's taking place
- Bayburt, Merkez, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bayburt, Merkez, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.